27-02-2023
Kedrion Biopharma joins Rare Disease Day
Read all
Raising awareness and generating change for the people living with a rare disease
01-09-2022
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Read all
Announced appointment of Ugo Di Francesco as CEO
10-02-2022
Results of the “Words in Hemophilia: Towards Patient Engagement” study have been published
Read all
The project supported by Kedrion defines some of the key principles intended to improve patient envolvement